Below is our recent interview with Kelly McDuff, Marketing Manager at Airway Management Inc. :
Q: Could you provide our readers with a brief introduction to your company?
A: Airway Management, Inc. is the manufacturer of the TAP Sleep Care system which offers four unique device categories that provide industry-leading snoring and sleep apnea treatment. Our devices range from non-custom oral appliances (myTAP) to hybrid custom oral appliances with CPAP masks. Since no two patients are the same, your sleep device therapy should offer a range of integrated options, suiting your patient’s individual needs. TAP has the most independent peer-reviewed studies published (50+) with best patient outcomes as compared to any other oral appliance on the market.
Q: Any highlights on your recent announcement?
A: A new study by the Academic Center for Dentistry Amsterdam (ACTA) shows myTAP is now proven equally effective as custom TAP, the most independently researched oral appliance in the world (50+ studies). This is the first randomized controlled trial (RCT) comparing a non-custom to a custom oral appliance.
Previous studies around traditional “boil-and-bite” appliances compared unlike designs and were less effective than custom-made oral medical devices.
The results of this new research, published by the Journal of Clinical Sleep Medicine (JCSM) in May 2022, supports the use of using a non-custom device.
Q: Can you give us more insights into your offering?
A: myTAP is an immediate first line treatment option for those suffering from mild to moderate sleep apnea.
These results come nearly one year following the initial announcement of the Philips CPAP recall. With rising CPAP shortages and lower rates of CPAP compliance, many distributors and clinicians are urgently seeking alternative solutions for their patients. myTAP™ is a proven, professional oral medical device available for immediatesubstitution.
Q: What can we expect from your company in next 6 months? What are your plans?
A: Our goal is to partner with more clinicians and companies to get more patients treated for their snoring and obstructive sleep apnea. With this new research and in lieu of the major CPAP recall, we expect to see a growth in myTAP users and ultimately a growth in patients using oral appliance therapy as first line treatment for obstructive sleep apnea.
Q: What is the best thing about your company that people might not know about?
A: The TAP Sleep Care system is the only system out there that is designed to treat the full spectrum of sleep related breathing disorders – from snoring to severe obstructive sleep apnea. We offer oral appliance therapy, nasal pillow masks for CPAP, and a unique hybrid therapy option for severe sleep apnea patients.
We pride ourselves in our innovation and research – TAP is the most studied custom oral appliance in the world. Airway Management holds over 70 patents for its technology.